| Drug Name |
Sulfasalazine |
| Drug ID |
BADD_D02093 |
| Description |
A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see mesalamine) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) |
| Indications and Usage |
For the treatment of Crohn's disease and rheumatoid arthritis as a second-line agent. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A07EC01 |
| DrugBank ID |
DB00795
|
| KEGG ID |
D00448
|
| MeSH ID |
D012460
|
| PubChem ID |
5339
|
| TTD Drug ID |
D02ZTJ
|
| NDC Product Code |
68071-4215; 23155-019; 70518-1829; 50090-0086; 49964-0018; 43353-495; 63629-5688; 70518-0185; 51927-0054; 51927-0081; 0591-0796; 0013-0101; 59762-0104; 38779-0176; 0013-0102; 50268-730; 59116-0632; 62705-0222; 62991-2704; 57294-021; 59116-0631; 71610-577; 59762-5000; 59116-0633; 59116-0630; 62135-960; 51552-1044; 50090-2013; 49452-7523; 68022-7065; 70518-2342 |
| Synonyms |
Sulfasalazine | Salicylazosulfapyridine | Sulphasalazine | Salazosulfapyridine | Pyralin EN | Azulfadine | Azulfidine EN | Azulfidine | Asulfidine | Colo-Pleon | Colo Pleon | Pleon | Ulcol | Sulfasalazin medac | Sulfasalazin-Heyl | Sulfasalazin Heyl | Sulfasalazine FNA | Ucine | Salazopyrin | ratio-Sulfasalazine | ratio Sulfasalazine |
